B cell function and influenza vaccine responses in healthy aging and disease

Current Opinion in Immunology

Volumn 29, Issue 1, 2014, Pages 112-118

  Frasca, Daniela ^a   Blomberg, Bonnie B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 10; MESSENGER RNA; VIRUS ANTIBODY;

ANTIBODY RESPONSE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONGESTIVE HEART FAILURE; CPG ISLAND; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VACCINATION; LYMPHOCYTE FUNCTION; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; SEASONAL INFLUENZA; AGING; ANIMAL; CARDIOVASCULAR DISEASE; IMMUNOLOGY;

AGING; ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HIV INFECTIONS; HUMANS; INFLUENZA VACCINES;

EID: 84902273706     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.05.008     Document Type: Review

References (72)

1. Finco O., Rappuoli R. Designing vaccines for the twenty-first century society. Front Immunol 2014, 5:12.
2. Yung C.F., Andrews N., Hoschler K., Miller E. Comparing the immunogenicity of AS03-adjuvanted 2009 pandemic H1N1 vaccine with clinical protection in priority risk groups in England. PLOS ONE 2013, 8:e56844.
3. Ferrucci L., Guralnik J.M., Pahor M., Corti M.C., Havlik R.J. Hospital diagnoses, medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997, 277:728-734.
4. Pilotto A., Panza F., Sancarlo D., Paroni G., Maggi S., Ferrucci L. Usefulness of the multidimensional prognostic index (MPI) in the management of older patients with chronic kidney disease. J Nephrol 2012, 25(Suppl. 19):S79-S84.
5. Monto A.S., Ansaldi F., Aspinall R., McElhaney J.E., Montano L.F., Nichol K.L., Puig-Barbera J., Schmitt J., Stephenson I. Influenza control in the 21st century: optimizing protection of older adults. Vaccine 2009, 27:5043-5053.
6. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
7. McMurry J.A., Johansson B.E., De Groot A.S. A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A. Hum Vaccin 2008, 4:148-157.
8. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.Y., Mays I., Garman L., Helms C., et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667-671.
9. Shi Y., Yamazaki T., Okubo Y., Uehara Y., Sugane K., Agematsu K. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 2005, 175:3262-3267.
10. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011, 29:621-663.
11. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995, 123:518-527.
12. Simonsen L., Clarke M.J., Schonberger L.B., Arden N.H., Cox N.J., Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998, 178:53-60.
13. Vu T., Farish S., Jenkins M., Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002, 20:1831-1836.
14. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994, 331:778-784.
15. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., Fukuda K. Influenza-associated hospitalizations in the United States. JAMA 2004, 292:1333-1340.
16. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006, 24:1159-1169.
17. McElhaney J.E. Influenza vaccine responses in older adults. Ageing Res Rev 2011, 10:379-388.
18. Colonna-Romano G., Bulati M., Aquino A., Scialabba G., Candore G., Lio D., Motta M., Malaguarnera M., Caruso C. B cells in the aged: CD27, CD5, and CD40 expression. Mech Ageing Dev 2003, 124:389-393.
19. Sambhara S., McElhaney J.E. Immunosenescence and influenza vaccine efficacy. Curr Top Microbiol Immunol 2009, 333:413-429.
20. Simonsen L., Taylor R.J., Viboud C., Miller M.A., Jackson L.A. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007, 7:658-666.
21. Solana R., Pawelec G., Tarazona R. Aging and innate immunity. Immunity 2006, 24:491-494.
22. Jing Y., Shaheen E., Drake R.R., Chen N., Gravenstein S., Deng Y. Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 2009, 70:777-784.
23. Panda A., Qian F., Mohanty S., van Duin D., Newman F.K., Zhang L., Chen S., Towle V., Belshe R.B., Fikrig E., et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010, 184:2518-2527.
24. Goronzy J.J., Lee W.W., Weyand C.M. Aging and T-cell diversity. Exp Gerontol 2007, 42:400-406.
25. Gupta S., Bi R., Su K., Yel L., Chiplunkar S., Gollapudi S. Characterization of naive, memory and effector CD8+ T cells: effect of age. Exp Gerontol 2004, 39:545-550.
26. Pawelec G., Barnett Y., Forsey R., Frasca D., Globerson A., McLeod J., Caruso C., Franceschi C., Fulop T., Gupta S., et al. T cells and aging, January 2002 update. Front Biosci 2002, 7:d1056-d1183.
27. Vallejo A.N. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 2005, 205:158-169.
28. Gibson K.L., Wu Y.C., Barnett Y., Duggan O., Vaughan R., Kondeatis E., Nilsson B.O., Wikby A., Kipling D., Dunn-Walters D.K. B-cell diversity decreases in old age and is correlated with poor health status. Aging Cell 2009, 8:18-25.
29. Olsson J., Wikby A., Johansson B., Lofgren S., Nilsson B.O., Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000, 121:187-201.
30. Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., Wikby A. Human immunosenescence: is it infectious?. Immunol Rev 2005, 205:257-268.
31. Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009, 19:47-56.
32. Ademokun A., Wu Y.C., Dunn-Walters D. The ageing B cell population: composition and function. Biogerontology 2010, 11:125-137.
33. Buffa S., Pellicano M., Bulati M., Martorana A., Goldeck D., Caruso C., Pawelec G., Colonna-Romano G. A novel B cell population revealed by a CD38/CD24 gating strategy: CD38(-)CD24(-) B cells in centenarian offspring and elderly people. Age (Dordr) 2013, 35:2009-2024.
34. Chong Y., Ikematsu H., Yamaji K., Nishimura M., Nabeshima S., Kashiwagi S., Hayashi J. CD27(+) (memory) B cell decrease and apoptosis-resistant CD27(-) (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances. Int Immunol 2005, 17:383-390.
35. Frasca D., Landin A.M., Lechner S.C., Ryan J.G., Schwartz R., Riley R.L., Blomberg B.B. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol 2008, 180:5283-5290.
36. Frasca D., Diaz A., Romero M., Landin A.M., Phillips M., Lechner S.C., Ryan J.G., Blomberg B.B. Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans. Vaccine 2010, 28:8077-8084.
37. Frasca D., Diaz A., Romero M., Phillips M., Mendez N.V., Landin A.M., Blomberg B.B. Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine. Int Immunol 2012, 24:175-182.
38. Khurana S., Frasca D., Blomberg B., Golding H. AID activity in B cells strongly correlates with polyclonal antibody affinity maturation in-vivo following pandemic 2009-H1N1 vaccination in humans. PLoS Pathog 2012, 8:e1002920.
39. Derhovanessian E., Theeten H., Hahnel K., Van Damme P., Cools N., Pawelec G. Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination. Vaccine 2013, 31:685-690.
40. Sasaki S., Sullivan M., Narvaez C.F., Holmes T.H., Furman D., Zheng N.Y., Nishtala M., Wrammert J., Smith K., James J.A., et al. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest 2011, 121:3109-3119.
41. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001, 75:12182-12187.
42. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., Parson W., Bock G., Schonitzer D., Trannoy E., et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002, 168:5893-5899.
43. McElhaney J.E., Zhou X., Talbot H.K., Soethout E., Bleackley R.C., Granville D.J., Pawelec G. The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 2012, 30:2060-2067.
44. Frasca D., Landin A.M., Alvarez J.P., Blackshear P.J., Riley R.L., Blomberg B.B. Tristetraprolin, a negative regulator of mRNA stability, is increased in old B cells and is involved in the degradation of E47 mRNA. J Immunol 2007, 179:918-927.
45. Frasca D., Diaz A., Romero M., Landin A.M., Blomberg B.B. High TNF-alpha levels in resting B cells negatively correlate with their response. Exp Gerontol 2014, 54:116-122.
46. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
47. Muramatsu M., Nagaoka H., Shinkura R., Begum N.A., Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 2007, 94:1-36.
48. Durandy A. Hyper-IgM syndromes: a model for studying the regulation of class switch recombination and somatic hypermutation generation. Biochem Soc Trans 2002, 30:815-818.
49. Dorsett Y., McBride K.M., Jankovic M., Gazumyan A., Thai T.H., Robbiani D.F., Di Virgilio M., Reina San-Martin B., Heidkamp G., Schwickert T.A., et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008, 28:630-638.
50. Teng G., Hakimpour P., Landgraf P., Rice A., Tuschl T., Casellas R., Papavasiliou F.N. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 2008, 28:621-629.
51. Jiang N., He J., Weinstein J.A., Penland L., Sasaki S., He X.S., Dekker C.L., Zheng N.Y., Huang M., Sullivan M., et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 2013, 5:171ra119.
52. Muller L.M., Gorter K.J., Hak E., Goudzwaard W.L., Schellevis F.G., Hoepelman A.I., Rutten G.E. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005, 41:281-288.
53. Eickhoff T.C., Sherman I.L., Serfling R.E. Observations on excess mortality associated with epidemic influenza. JAMA 1961, 176:776-782.
54. Pozzilli P., Gale E.A., Visalli N., Baroni M., Crovari P., Frighi V., Cavallo M.G., Andreani D. The immune response to influenza vaccination in diabetic patients. Diabetologia 1986, 29:850-854.
55. McElhaney J.E., Pinkoski M.J., Au D., Lechelt K.E., Bleackley R.C., Meneilly G.S. Helper and cytotoxic T lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly. Vaccine 1996, 14:539-544.
56. Frasca D., Diaz A., Romero M., Mendez N.V., Landin A.M., Ryan J.G., Blomberg B.B. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013, 31:3603-3610.
57. Frasca D., Romero M., Diaz A., Alter-Wolf S., Ratliff M., Landin A.M., Riley R.L., Blomberg B.B. A molecular mechanism for TNF-alpha-mediated downregulation of B cell responses. J Immunol 2012, 188:279-286.
58. Moir S., Fauci A.S. Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. J Allergy Clin Immunol 2008, 122:12-19. (quiz 20-11).
59. Parmigiani A., Alcaide M.L., Freguja R., Pallikkuth S., Frasca D., Fischl M.A., Pahwa S. Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation. PLOS ONE 2013, 8:e79816.
60. Cohen C., Simonsen L., Sample J., Kang J.W., Miller M., Madhi S.A., Campsmith M., Viboud C. Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America. Clin Infect Dis 2012, 55:996-1003.
61. Sheth A.N., Patel P., Peters P.J. Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic. Curr HIV/AIDS Rep 2011, 8:181-191.
62. Malaspina A., Moir S., Orsega S.M., Vasquez J., Miller N.J., Donoghue E.T., Kottilil S., Gezmu M., Follmann D., Vodeiko G.M., et al. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 2005, 191:1442-1450.
63. Tebas P., Frank I., Lewis M., Quinn J., Zifchak L., Thomas A., Kenney T., Kappes R., Wagner W., Maffei K., et al. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals. AIDS 2010, 24:2187-2192.
64. Cagigi A., Pensieroso S., Ruffin N., Sammicheli S., Thorstensson R., Pan-Hammarstrom Q., Hejdeman B., Nilsson A., Chiodi F. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients. Vaccine 2013, 31:2231-2237.
65. Chou J.P., Ramirez C.M., Wu J.E., Effros R.B. Accelerated aging in HIV/AIDS: novel biomarkers of senescent human CD8+ T cells. PLOS ONE 2013, 8:e64702.
66. Pommier J.P., Gauthier L., Livartowski J., Galanaud P., Boue F., Dulioust A., Marce D., Ducray C., Sabatier L., Lebeau J., et al. Immunosenescence in HIV pathogenesis. Virology 1997, 231:148-154.
67. Smith S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., Grundy S.M., Hiratzka L., Jones D., Krumholz H.M., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006, 113:2363-2372.
68. Douglas R.G., Betts R.F., Simons R.L., Hogan P.W., Roth F.K. Evaluation of a topical interferon inducer in experimental influenza infection in volunteers. Antimicrob Agents Chemother 1975, 8:684-687.
69. Glezen W.P., Decker M., Perrotta D.M. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis 1987, 136:550-555.
70. De Martinis M., Franceschi C., Monti D., Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett 2005, 579:2035-2039.
71. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., Ewen C., Kane K.P., Bleackley R.C. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006, 176:6333-6339.
72. Vardeny O., Moran J.J., Sweitzer N.K., Johnson M.R., Hayney M.S. Decreased T-cell responses to influenza vaccination in patients with heart failure. Pharmacotherapy 2010, 30:10-16.